Reaction

Nasal Discharge Discolouration reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,364 reports · 53 co-occurring drugs

As of the last recalculation, Nasal Discharge Discolouration appears in 1,364 FAERS reports alongside 53 co-occurring drug terms. The strongest observed disproportionality signal is LEVODOPA (PRR 118.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Levodopa	88	118.7	119.6
Ciclesonide	43	49.7	49.9
Omalizumab	220	46.8	46.9
Brinzolamide	20	35.6	35.7
Esomeprazole Magnesium Capsule, Delayed Release	31	33.3	33.4
Esomeprazole Magnesium Delayed Release Capsules	31	33.3	33.4
Esomeprazole Magnesium Dihydrate	31	33.2	33.3
Fluticasone Propionate And Salmeterol Xinafoate	111	30.6	30.7
Rizatriptan Benzoate	20	30.4	30.5
Mupirocin Calcium	23	26.0	26.0
Standardized Senna Concentrate	21	25.9	25.9
Mupirocin	22	25.3	25.3
Montelukast Sodium	161	22.7	22.8
Ipratropium Bromide	49	21.7	21.7
Mepolizumab	66	21.2	21.3
Rosuvastatin Calcium	37	20.6	20.6
Octreotide Acetate	39	20.0	20.0
Infliximab-Dyyb	37	19.8	19.9
Fluticasone Propionate Nasal	38	19.7	19.7
Budesonide And Formoterol Fumarate Dihydrate	99	16.7	16.7
Fluticasone Furoate And Vilanterol Trifenatate	38	16.6	16.6
Desoximetasone	20	16.2	16.3
Cetirizine Hcl	9	15.1	15.1
Montelukast	72	13.8	13.8
Albuterol Sulfate	208	12.4	12.4
Mometasone Furoate	32	12.0	12.0
Cyclobenzaprine	38	11.9	11.9
Epinephrine	48	11.6	11.6
Quetiapine Fumarate	22	11.5	11.6
Fluticasone Furoate	9	11.4	11.4
Tiotropium Bromide	91	10.8	10.8
Cetirizine Hydrochloride Allergy	21	10.7	10.7
Cetirizine Hydrochloride Tablets	21	10.7	10.7
Cetirizine	49	10.0	10.0
Amantadine	10	9.9	9.9
Rasagiline Mesylate	7	9.6	9.6
Epoprostenol	8	9.4	9.4
Carbidopa And Levodopa	28	9.2	9.2
Sunitinib Malate	23	9.1	9.1
Rotigotine	8	8.5	8.5
Vilazodone Hydrochloride	5	8.3	8.3
Latanoprost	26	8.0	8.0
Everolimus	26	7.9	7.9
Canakinumab	5	7.1	7.1
Mometasone Furoate And Formoterol Fumarate Dihydrate	7	6.9	6.9
Vedolizumab	34	6.2	6.2
Lifitegrast	6	5.6	5.6
Lumacaftor And Ivacaftor	3	5.4	5.4
Elexacaftor, Tezacaftor, And Ivacaftor	4	4.9	4.9
Palivizumab	4	4.0	4.0
Ambrisentan	31	3.9	3.9
Dupilumab	82	2.7	2.7
Nirmatrelvir And Ritonavir	6	1.7	1.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.